Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents

Pharmacology and Therapeutics

Volumn 109, Issue 3, 2006, Pages 366-398

  Lugnier, Claire ^a  

^a CNRS   (France)

Author keywords

Angiogenesis; Cell cycle; Cyclic AMP; Cyclic GMP; Disease; Expression; Inflammation; Intracellular signaling; Phosphodiesterase (PDE)

Indexed keywords

1 (3 CHLOROANILINO) 4 PHENYLPHTHALAZINE; 2 METHYL 5 NITROBENZENESULFONIC ACID DIMETHYLAMIDE; 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 4,5 DIHYDRO 6 [4 (1H IMIDAZOL 1 YL)PHENYL] 5 METHYL 3(2H) PYRIDAZINONE; AMRINONE; CILOMILAST; CILOSTAMIDE; CILOSTAZOL; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; DIPYRIDAMOLE; ENOXIMONE; ENZYME INHIBITOR; IC 224; MILRINONE; NIMODIPINE; OPC 33540; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; PIMOBENDAN; PIROXIMONE; ROFLUMILAST; ROLIPRAM; SCH 51866; SILDENAFIL; SULMAZOLE; TADALAFIL; TREQUINSIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VARDENAFIL; ZAPRINAST;

CELL FUNCTION; CELLULAR DISTRIBUTION; CLINICAL TRIAL; DRUG INHIBITION; DRUG POTENTIATION; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME STRUCTURE; HUMAN; HYDROLYSIS; INFLAMMATION; INTERMITTENT CLAUDICATION; MAMMAL CELL; MULTIGENE FAMILY; NERVE DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; CYCLIC AMP; CYCLIC GMP; ENDOTHELIAL CELLS; HUMANS; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES;

EID: 31144433061     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.07.003     Document Type: Review

References (380)

1. H. Abrahamsen, G. Baillie, J. Ngai, T. Vang, K. Nika, and A. Ruppelt TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling J Immunol 173 2004 4847 4858
2. H.S. Ahn, A. Bercovici, G. Boykow, A. Bronnenkant, S. Chackalamannil, and J. Chow Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity J Med Chem 40 1997 2196 2210
3. R.P. Alexander, G.J. Warrellow, M.A. Eaton, E.C. Boyd, J.C. Head, and J.R. Porter A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitors Bioorg Med Chem Lett 12 2002 1451 1456 (CDP840)
4. S.G. Andreeva, P. Dikkes, P.M. Epstein, and P.A. Rosenberg Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain J Neurosci 21 2001 9068 9076
5. N.O. Artemyev, R. Surendran, J.C. Lee, and H.E. Hamm Subunit structure of rod cGMP-phosphodiesterase J Biol Chem 271 1996 25382 25388
6. T. Asano, Y. Ochiai, and H. Hidaka Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors Mol Pharmacol 13 1997 400 406
7. D.F. Ashman, R. Lipton, M.M. Melicow, and T.D. Price Isolation of adenosine 3′, 5′-monophosphate and guanosine 3′, 5′-monophosphate from rat urine Biochem Biophys Res Commun 11 1963 330 334
8. A.L. Asirvatham, S.G. Galligan, R.V. Schillace, M.P. Davey, V. Vasta, and J.A. Beavo A-kinase anchoring proteins interact with phosphodiesterases in T lymphocyte cell lines J Immunol 173 2004 4806 4814
9. R. Auerbach, L. Kubai, D. Knighton, and J. Folkman A simple procedure for the long-term cultivation of chicken embryos Dev Biol 41 1974 391 394
10. P.A. Baecker, R. Obernolte, C. Bach, C. Yee, and E.R. Shelton Isolation of a cDNA encoding a human rolipram-sensitive cyclic AMP phosphodiesterase (PDE IVD) Gene 138 1994 253 256
11. G.S. Baillie, A. Sood, I. McPhee, I. Gall, S.J. Perry, and R.J. Lefkowitz Beta-arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi Proc Natl Acad Sci U S A 100 2003 940 945
12. R. Barber, G.S. Baillie, R. Bergmann, M.C. Shepherd, R. Sepper, and M.D. Houslay Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers Am J Physiol Lung Cell Mol Physiol 287 2004 L332 L343
13. M.S. Barnette, M. Grous, L.B. Cieslinski, M. Burman, S.B. Christensen, and T.J. Torphy Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a high-affinity rolipram binding site J Pharmacol Exp Ther 273 1995 1396 1402
14. M.S. Barnette, C.D. Manning, L.B. Cieslinski, M. Burman, S. Christensen, and B. Torphy The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity J Pharmacol Exp Ther 273 1995 674 679
15. M.B. Beard, A.E. Olsen, R.E. Jones, S. Erdogan, M.D. Houslay, and G.B. Bolger UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions J Biol Chem 275 2000 10349 10358
16. J.A. Beavo Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms Physiol Rev 75 1995 725 748
17. J.A. Beavo, J.G. Hardman, and E.W. Sutherland Stimulation of adenosine 3′,5′-monophosphate hydrolysis by guanosine 3′,5′- monophosphate J Biol Chem 246 1971 3841 3846
18. A.T. Bender, and J.A. Beavo Differentiation of human monocytes in vitro with granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor produces distinct changes in cGMP phosphodiesterase expression Cell Signal 16 2004 365 374
19. J.K. Bentley, D.M. Juilfs, and M.D. Uhler Nerve growth factor inhibits PC12 cell PDE 2 phosphodiesterase activity and increases PDE 2 binding to phosphoproteins J Neurochem 76 2001 1252 1263
20. H. Bergstrand, J. Kristoffersson, B. Lundquist, and A. Schurmann Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3′,5′-monophosphate and guanosine cyclic 3′,5′- monophosphate phosphodiesterases Mol Pharmacol 13 1977 38 43
21. M.M. Billah, N. Cooper, M. Minnicozzi, J. Warneck, P. Wang, and J.A. Hey Pharmacology of N-(3,5-dichloro-1-oxido-4-pyridinyl)-8-methoxy-2- (trifluoromethyl)-5-quinoline carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitor J Pharmacol Exp Ther 302 2002 127 137
22. T.J. Bloom, and J.A. Beavo Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants Proc Natl Acad Sci U S A 93 1996 14188 14192
23. F.G. Boess, M. Hendrix, F.J. van der Staay, C. Erb, R. Schreiber, and W. van Staveren Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance Neuropharmacology 47 2004 1081 1092
24. E. Boichot, J.L. Wallace, N. Germain, M. Corbel, C. Lugnier, and V. Lagente Anti-inflammatory activities of a new series of selective phosphodiesterase 4 inhibitors derived from 9-benzyladenine J Pharmacol Exp Ther 292 2000 647 653
25. G. Bolger, T. Michaeli, T. Martins, T. St John, B. Steiner, and L. Rodgers A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs Mol Cell Biol 13 1993 6558 6571
26. M. Boolell, M.J. Allen, S.A. Ballard, S. Gepi-Attee, G.J. Muirhead, and A.M. Naylor Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction Int J Impot Res 8 1996 47 52
27. J.J. Bourguignon, L. Desaubry, P. Raboisson, C.G. Wermuth, and C. Lugnier 9-Benzyladenines: potent and selective cAMP phosphodiesterase inhibitors J Med Chem 40 1997 1768 1770
28. R. Bourtchouladze, R. Lidge, R. Catapano, J. Stanley, S. Gossweiler, and D. Romashko Mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4 Proc Natl Acad Sci U S A 100 2003 10518 10522
29. J.A. Bristol, I. Sircar, W.H. Moos, D.B. Evans, and R.E. Weishaar Cardiotonic agents: 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3 (2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure J Med Chem 27 1984 1099 1101
30. D. Brunkhorst, H. von der Leyen, W. Meyer, R. Nigbur, C. Schmidt-Schumacher, and H. Scholz Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart Naunyn Schmiedebergs Arch Pharmacol 339 1989 575 583
31. R.W. Butcher, and E.W. Sutherland Adenosine 3′, 5′-phosphate in biological materials: 1. Purification and properties of cyclic 3′, 5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′, 5′-phosphate in human urine J Biol Chem 237 1962 1244 1250
32. I.L. Buxton, and L.L. Brunton Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes J Biol Chem 258 1983 10233 10239
33. M. Chabre, J. Bigay, F. Bruckert, F. Bornancin, P. Deterre, and C. Pfister Visual signal transduction: the cycle of transducin shuttling between rhodopsin and cGMP phosphodiesterase Cold Spring Harb Symp Quant Biol 1 1988 313 324
34. H. Charbonneau, R.K. Prusti, H. LeTrong, W.K. Sonnenburg, P.J. Mullaney, and K.A. Walsh Identification of a noncatalytic cGMP-binding domain conserved in both the cGMP-stimulated and photoreceptor cyclic nucleotide phosphodiesterases Proc Natl Acad Sci U S A 87 1990 288 292
35. M. Chasin, and D.N. Harris Inhibitory and activators of cyclic nucleotide phosphodiesterase Adv Cycl Nucleotide Res 7 1976 225 264
36. W.Y. Cheung Cyclic 3′,5′-nucleotide phosphodiesterase. Demonstration of an activator Biochem Biophys Res Commun 38 1970 533 538
37. P.P. Cheung, H. Xu, M.M. McLaughlin, F.A. Ghazaleh, G.P. Livi, and R.W. Colman Human platelet cGI-PDE: expression in yeast and localization of the catalytic domain by deletion mutagenesis Blood 88 1996 1321 1329
38. S.B. Christensen, A. Guider, C.J. Forster, J.G. Gleason, P.E. Bender, and J.M. Karpinski 1,4-Cyclohexanecarboxylates: potent and selective inhibitors of phosophodiesterase 4 for the treatment of asthma J Med Chem 41 1998 821 835
39. D. Claveau, S.L. Chen, S. O'Keefe, D.M. Zaller, A. Styhler, and S. Liu Preferential inhibition of T helper 1, but not T helper 2, cytokines in vitro by L-826,141 [4-[2-(3,4-Bisdifluromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2- hydroxypropan-2-yl)-phenyl]-ethyl]3-methylpyridine-1-oxide], a potent and selective phosphodiesterase 4 inhibitor J Pharmacol Exp Ther 310 2004 752 760
40. M. Conti Phosphodiesterases and cyclic nucleotide signaling in endocrine cells Mol Endocrinol 14 2000 1317 1327
41. M. Conti, S. Iona, M. Cuomo, J.V. Swinnen, J. Odeh, and M.E. Svoboda Characterization of a hormone-inducible, high affinity adenosine 3′-5′-cyclic monophosphate phosphodiesterase from the rat Sertoli cell Biochemistry 34 1995 7979 7987
42. M. Conti, W. Richter, C. Mehats, G. Livera, J.Y. Park, and C. Jin Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling J Biol Chem 278 2003 5493 5496
43. N.J. Cook, W. Hanke, and U.B. Kaupp Identification, purification, and functional reconstitution of the cyclic GMP-dependent channel from rod photoreceptors Proc Natl Acad Sci U S A 84 1987 585 589
44. J.F. Coquil, N. Virmaux, P. Mandel, and C. Goridis Cyclic nucleotide phosphodiesterase of retinal photoreceptors. Partial purification and some properties of the enzyme Biochim Biophys Acta 403 1975 425 437
45. J.F. Coquil, D.J. Franks, J.N. Wells, M. Dupuis, and P. Hamet Characteristics of a new binding protein distinct from the kinase for guanosine 3′:5′-monophosphate in rat platelets Biochim Biophys Acta 631 1980 148 165
46. J.D. Corbin, I.V. Turko, A. Beasley, and S.H. Francis Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities Eur J Biochem 267 2000 2760 2767
47. H. Coste, and P. Grondin Characterization of a novel potent and specific inhibitor of type V phosphodiesterase Biochem Pharmacol 50 1995 1577 1585
48. R.H. Cote Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5 Int J Impot Res 16 Suppl 1 2004 S28 S33
49. C. Coudray, C. Charon, N. Komas, G. Mory, F. Diot-Dupuy, and V. Manganiello Evidence for the presence of several phosphodiesterase isoforms in brown adipose tissue of Zucker rats: modulation of PDE2 by the fa gene expression FEBS Lett 456 1999 207 210
50. J.M. Cruickshank Phosphodiesterase III inhibitors: long-term risks and short-term benefits Cardiovasc Drugs Ther 7 1993 655 660
51. M.R. D'Amours, A.E. Granovsky, N.O. Artemyev, and R.H. Cote Potency and mechanism of action of E4021, a type 5 phosphodiesterase isozyme-selective inhibitor, on the photoreceptor phosphodiesterase depend on the state of activation of the enzyme Mol Pharmacol 55 1999 508 514
52. A. Daugan, P. Grondin, C. Ruault, A.C. Le Monnier de Gouville, H. Coste, and J.M. Linget The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4- b]indole-1,4-dione analogues J Med Chem 46 2003 4533 4542
53. E. Degerman, P. Belfrage, A.H. Newman, K.C. Rice, and V.C. Manganiello Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand J Biol Chem 262 1987 5797 5807
54. m cAMP phosphodiesterase in rat fat cells by phosphorylation Proc Natl Acad Sci U S A 87 1990 533 537
55. M.L. Dell'Acqua, and J.D. Scott Protein kinase A anchoring J Biol Chem 272 1997 12881 12884
56. J. de Rooij, F.J. Zwartkruis, M.H. Verheijen, R.H. Cool, S.M. Nijman, and A. Wittinghofer Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP Nature 396 1998 474 477
57. K.L. Dodge, S. Khouangsathiene, M.S. Kapiloff, R. Mouton, E.V. Hill, and M.D. Houslay mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module EMBO J 20 2001 1921 1930
58. R. Draheim, U. Egerland, and C. Rundfeldt Anti-inflammatory potential of the selective phosphodiesterase 4 inhibitor N-(3,5-dichloro-pyrid-4-yl)-[1-(4- fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), in human cell preparations J Pharmacol Exp Ther 308 2004 555 563
59. A.E. Eckly, and C. Lugnier Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway Br J Pharmacol 113 1994 445 450
60. A.E. Eckly-Michel, A. Le Bec, and C. Lugnier Chelerythrine, a protein kinase C inhibitor, interacts with cyclic nucleotide phosphodiesterases Eur J Pharmacol 324 1997 85 88
61. A. Eckly-Michel, V. Martin, and C. Lugnier Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation Br J Pharmacol 122 1997 158 164
62. S. Eddahibi, B. Raffestin, A.C. Le Monnier de Gouville, and S. Adnot Effect of DMPPO, a phosphodiesterase type 5 inhibitor, on hypoxic pulmonary hypertension in rats Br J Pharmacol 125 1998 681 688
63. S.D. Edmondson, A. Mastracchio, J. He, C.C. Chung, M.J. Forrest, and S. Hofsess Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors Bioorg Med Chem 13 2003 3983 3987
64. P. Engels, M. Sullivan, T. Muller, and H. Lubbert Molecular cloning and functional expression in yeast of a human cAMP-specific phosphodiesterase subtype (PDE IV-C) FEBS Lett 358 1995 305 310
65. P.M. Epstein, K. Fiss, R. Hachisu, and D.M. Andrenyak Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin Biochem Biophys Res Commun 105 1982 1142 1149
66. C. Erneux, D. Couchie, J.E. Dumont, J. Baraniak, W.J. Stec, and E.G. Abbad Specificity of cyclic GMP activation of a multi-substrate cyclic nucleotide phosphodiesterase from rat liver Eur J Biochem 115 1981 503 510
67. L. Favot, T. Keravis, V. Holl, A. Le Bec, and C. Lugnier VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors Thromb Haemost 90 2003 334 343
68. L. Favot, T. Keravis, and C. Lugnier Modulation of VEGF-induced endothelial cell cycle protein expression through cyclic AMP hydrolysis by PDE2 and PDE4 Thromb Haemost 92 2004 634 645
69. L. Fawcett, R. Baxendale, P. Stacey, C. McGrouther, I. Harrow, and S. Soderling Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A Proc Natl Acad Sci U S A 97 2000 3702 3707
70. M. Fidock, M. Miller, and J. Lanfear Isolation and differential tissue distribution of two human cDNAs encoding PDE1 splice variants Cell Signal 14 2002 53 60
71. m cyclic AMP phosphodiesterases in cardiac cells Mol Pharmacol 38 1990 426 433
72. D.A. Fisher, J.F. Smith, J.S. Pillar, S.H. St Denis, and J.B. Cheng Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase Biochem Biophys Res Commun 246 1998 570 577
73. D.A. Fisher, J.F. Smith, J.S. Pillar, S.H. St Denis, and J.B. Cheng Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase J Biol Chem 273 1998 15559 15564
74. S.K. Florio, R.K. Prusti, and J.A. Beavo Solubilization of membrane-bound rod phosphodiesterase by the rod phosphodiesterase recombinant delta subunit J Biol Chem 271 1996 24036 24047
75. L.R. Forte, P.K. Thorne, S.L. Eber, W.J. Krause, R.H. Freeman, and S.H. Francis Stimulation of intestinal Cl-transport by heat-stable enterotoxin: activation of cAMP-dependent protein kinase by cGMP Am J Physiol 263 1992 C607 C615
76. S.H. Francis, and J.D. Corbin Purification of cGMP-binding protein phosphodiesterase from rat lung Methods Enzymol 159 1988 722 729
77. S.H. Francis, and J.D. Corbin Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action Crit Rev Clin Lab Sci 36 1999 275 328
78. S.H. Francis, T.M. Lincoln, and J.D. Corbin Characterization of a novel cGMP binding protein from rat lung J Biol Chem 255 1980 620 626
79. S.H. Francis, I.V. Turko, and J.D. Corbin Cyclic nucleotide phosphodiesterases: relating structure and function Prog Nucleic Acid Res Mol Biol 65 2001 1 52
80. S.H. Francis, E.P. Bessay, J. Kotera, K.A. Grimes, L. Liu, and W.J. Thompson Phosphorylation of isolated human phosphodiesterase-5 regulatory domain induces an apparent conformational change and increases cGMP binding affinity J Biol Chem 277 2002 47581 47587
81. K. Fujishige, J. Kotera, H. Michibata, K. Yuasa, S. Takebayashi, and K. Okumura Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A) J Biol Chem 274 1999 18438 18445
82. K. Fujishige, J. Kotera, K. Yuasa, and K. Omori The human phosphodiesterase PDE10A gene genomic organization and evolutionary relatedness with other PDEs containing GAF domains Eur J Biochem 267 2000 5943 5951
83. D.D. Gale, L.J. Landells, D. Spina, A.J. Miller, K. Smith, and T. Nichols Pharmacokinetic and pharmacodynamic profile following oral administration of the phosphodiesterase (PDE)4 inhibitor V11294A in healthy volunteers Br J Clin Pharmacol 54 2002 478 484
84. C. Gardner, N. Robas, D. Cawkill, and M. Fidock Related Cloning and characterization of the human and mouse PDE7B, a novel cAMP-specific cyclic nucleotide phosphodiesterase Biochem Biophys Res Commun 272 2000 186 192
85. V. Geoffroy, F. Fouque, V. Nivet, J.P. Clot, C. Lugnier, and B. Desbuquois Activation of a cGMP-stimulated cAMP phosphodiesterase by protein kinase C in a liver Golgi-endosomal fraction Eur J Biochem 259 1999 892 900
86. V. Geoffroy, F. Fouque, C. Lugnier, B. Desbuquois, and C. Benelli Characterization of an in vivo hormonally regulated phosphodiesterase 3 (PDE3) associated with a liver Golgi-endosomal fraction Arch Biochem Biophys 387 2001 154 162
87. M. Georget, P. Mateo, G. Vandecasteele, L. Lipskaia, N. Defer, and J. Hanoune Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8) FASEB J 17 2003 1380 1391
88. P.G. Gillespie, and J.A. Beavo Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948 Mol Pharmacol 36 1989 773 781
89. D. Giordano, M. Giorgi, C. Sette, S. Biagioni, and G. Augusti-Tocco cAMP-dependent induction of PDE5 expression in murine neuroblastoma cell differentiation FEBS Lett 446 1999 218 222
90. D. Giordano, M.E. De Stefano, G. Citro, A. Modica, and M. Giorgi Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain Biochim Biophys Acta 1539 2001 16 27
91. M. Giorgi, D. Giordano, J. Rosati, A.M. Tata, and G. Augusti-Tocco Differential expression and localization of calmodulin-dependent phosphodiesterase genes during ontogenesis of chick dorsal root ganglion J Neurochem 80 2002 970 979
92. N.A. Glavas, C. Ostenson, J.B. Schaefer, V. Vasta, and J.A. Beavo T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3 Proc Natl Acad Sci U S A 98 2001 6319 6324
93. B. Gong, O.V. Vitolo, F. Trinchese, S. Liu, M. Shelanski, and O. Arancio Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment J Clin Invest 114 2004 1624 1634
94. 2+ calmodulin-dependent phosphodiesterase 1A (PDE1A) J Biol Chem 279 2004 40494 40504
95. C. Goridis, and N. Virmaux Light-regulated guanosine 3′,5′- monophosphate phosphodiesterase of bovine retina Nature 248 1974 57 58
96. U. Gresser, and C.H. Gleiter Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil-review of the literature Eur J Med Res 7 2002 435 446
97. D. Guay, P. Hamel, M. Blouin, C. Brideau, C.C. Chan, and N. Chauret Discovery of L-791,943: a potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor Bioorg Med Chem Lett 12 2002 1457 1461
98. M. Guipponi, H.S. Scott, J. Kudoh, K. Kawasaki, K. Shibuya, and A. Shintani Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22.3: alternative splicing of mRNA transcripts, genomic structure and sequence Hum Genet 103 1998 386 392
99. A.B. Gustafsson, and L.L. Brunton Attenuation of cAMP accumulation in adult rat cardiac fibroblasts by IL-1beta and NO: role of cGMP-stimulated PDE2 Am J Physiol Cell Physiol 283 2002 C463 C471
100. M. Hagiwara, T. Endo, and H. Hidaka Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle Biochem Pharmacol 33 1984 453 457
101. P. Hamet, and J.F. Coquil Cyclic GMP binding and cyclic GMP phosphodiesterase in rat platelets J Cycl Nucleotide Res 4 1978 281 290
102. S.E. Hamilton, and J.B. Hurley A phosphodiesterase inhibitor specific to a subset of bovine retinal cones J Biol Chem 265 1990 11259 11264
103. P. Han, X. Zhu, and T. Michaeli Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart J Biol Chem 272 1997 16152 16157
104. P. Han, J. Werber, M. Surana, N. Fleischer, and T. Michaeli The calcium/calmodulin-dependent phosphodiesterase PDE1C down-regulates glucose-induced insulin secretion J Biol Chem 274 1999 22337 22344
105. G. Hansen, S. Jin, D.T. Umetsu, and M. Conti Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D Proc Natl Acad Sci U S A 97 2000 6751 6756
106. K.A. Hanson, F. Burns, S.D. Rybalkin, J.W. Miller, J. Beavo, and W.R. Clarke Developmental changes in lung cGMP phosphodiesterase-5 activity, protein, and message Am J Respir Crit Care Med 158 1998 279 288
107. K.A. Hanson, J.W. Ziegler, S.D. Rybalkin, J.W. Miller, S.H. Abman, and W.R. Clarke Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity Am J Physiol 275 1998 L931 L941
108. L. Harndahl, N. Wierup, S. Enerback, H. Mulder, V.C. Manganiello, and F. Sundler Beta-cell-targeted overexpression of phosphodiesterase 3B in mice causes impaired insulin secretion, glucose intolerance, and deranged islet morphology J Biol Chem 279 2004 15214 15222
109. A.L. Harris, B.M. Lemp, R.G. Bentley, M.H. Perrone, L.T. Hamel, and P.J. Silver Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor J Pharmacol Exp Ther 249 1989 394 400
110. S.A. Harrison, D.H. Reifsnyder, B. Gallis, G.G. Cadd, and J.A. Beavo Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs Mol Pharmacol 29 1986 506 514
111. H.C. Hartzell, and R. Fischmeister Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells Nature 323 1986 273 275
112. Y. Hashimoto, R.K. Sharma, and T.R. Soderling Regulation of Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase by the autophosphorylated form of Ca2+/calmodulin-dependent protein kinase II J Biol Chem 264 1989 10884 10887
113. R.J. Haslam, N.T. Dickinson, and E.K. Jang Cyclic nucleotides and phosphodiesterases in platelets Thromb Haemost 82 1999 412 423
114. A. Hatzelmann, and C. Schudt Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro J Pharmacol Exp Ther 297 2001 267 279
115. M. Hayashi, K. Matsushima, H. Ohashi, H. Tsunoda, S. Murase, and Y. Kawarada Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3′,5′-cyclic nucleotide phosphodiesterase Biochem Biophys Res Commun. 250 1998 751 756
116. F. Hayashi, I. Matsuura, S. Kachi, T. Maeda, M. Yamamoto, and Y. Fujii Phosphorylation by cyclin-dependent protein kinase 5 of the regulatory subunit of retinal cGMP phosphodiesterase: II. Its role in the turnoff of phosphodiesterase in vivo J Biol Chem 275 2000 32958 32965
117. M. Hayashi, Y. Shimada, Y. Nishimura, T. Hama, and T. Tanaka Genomic organization, chromosomal localization, and alternative splicing of the human phosphodiesterase 8B gene Biochem Biophys Res Commun 297 2002 1253 1258
118. J. Haynes Jr., D.W. Killilea, P.D. Peterson, and W.J. Thompson Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3′,5′-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung J Pharmacol Exp Ther 276 1996 752 757
119. R. He, N. Komas, D. Ekholm, T. Murata, M. Taira, and S. Hockman Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3) Cell Biochem Biophys 29 1998 89 111
120. A.L. Hebb, H.A. Robertson, and E.M. Denovan-Wright Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of neuroscience Neuroscience 123 2004 967 981
121. J.M. Hetman, N. Robas, R. Baxendale, M. Fidock, S.C. Phillips, and S.H. Soderling Cloning and characterization of two splice variants of human phosphodiesterase 11A Proc Natl Acad Sci U S A 97 2000 12891 12895
122. M.F. Hibert, M.W. Gittos, D.N. Middlemiss, A.K. Mir, and J.R. Fozard Graphics computer-aided receptor mapping as a predictive tool for drug design: development of potent, selective, and stereospecific ligands for the 5-HT1A receptor J Med Chem 31 1988 1087 1093
123. M.F. Hibert, S. Trumpp-Kallmeyer, A. Bruinvels, and J. Hoflack Three-dimensional models of neurotransmitter G-binding protein-coupled receptors Mol Pharmacol 40 1991 8 15
124. H. Hidaka, H. Hayashi, H. Kohri, Y. Kimura, T. Hosokawa, and T. Igawa Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation J Pharmacol Exp Ther 211 1979 26 30
125. Y.S. Ho, L.M. Burden, and J.H. Hurley Structure of the GAF domain, a ubiquitous signaling motif and a new class of cyclic GMP receptor EMBO J 19 2000 5288 5299
126. M.D. Houslay, and D.R. Adams PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization Biochem J 370 2003 1 18
127. M.D. Houslay, M. Sullivan, and G.B. Bolger The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions Adv Pharmacol 44 1998 225 342
128. H. Hu, E.A. McCaw, A.L. Hebb, G.T. Gomez, and E.M. Denovan-Wright Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A Eur J Neurosci 20 2004 3351 3363
129. Q. Huai, J. Colicelli, and H. Ke The crystal structure of AMP-bound PDE4 suggests a mechanism for phosphodiesterase catalysis Biochemistry 42 2003 13220 13226
130. Q. Huai, Y. Liu, S.H. Francis, J.D. Corbin, and H. Ke Crystal structures of phosphodiesterases 4 and 5 in complex with inhibitor 3-isobutyl-1- methylxanthine suggest a conformation determinant of inhibitor selectivity J Biol Chem 279 2004 13095 130101
131. 2+ to calmodulin for activation Proc Natl Acad Sci U S A 78 1981 871 874
132. D. Huang, T.R. Hinds, S.E. Martinez, C. Doneanu, and J.A. Beavo Molecular determinants of cGMP binding to chicken cone photoreceptor phosphodiesterase J Biol Chem 279 2004 48143 48151
133. E. Huston, M. Beard, F. McCallum, N.J. Pyne, P. Vandenabeele, and G. Scotland The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3. Consequences for altered intracellular distribution J Biol Chem 275 2000 28063 28074
134. M. Ichimura, and H. Kase A new cyclic nucleotide phosphodiesterase isozyme expressed in the T-lymphocyte cell lines Biochem Biophys Res Commun 193 1993 985 990
135. M. Ichimura, R. Eiki, K. Osawa, S. Nakanishi, and H. Kase KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase Biochem J 316 1996 311 316
136. N. Ilan, S. Mahooti, D.L. Rimm, and J.A. Madri Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis J Cell Sci 111 1998 3621 3631
137. S. Iona, M. Cuomo, T. Bushnik, F. Naro, C. Sette, and M. Hess Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain Mol Pharmacol 53 1998 23 32
138. S. Jacobitz, M.M. McLaughlin, G.P. Livi, M. Burman, and T.J. Torphy Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding Mol Pharmacol 50 1996 891 899
139. H. Jiang, J.L. Colbran, S.H. Francis, and J.D. Corbin Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries J Biol Chem 267 1992 1015 1019
140. X. Jiang, J. Li, M. Paskind, and P.M. Epstein Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells Proc Natl Acad Sci U S A 93 1996 11236 11241
141. S.L. Jin, and M. Conti Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses Proc Natl Acad Sci U S A 99 2002 7628 7633
142. S.L. Jin, F.J. Richard, W.P. Kuo, A.J. D'Ercole, and M. Conti Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice Proc Natl Acad Sci U S A 96 1999 11998 12003
143. D.M. Juilfs, H.J. Fulle, A.Z. Zhao, M.D. Houslay, D.L. Garbers, and J.A. Beavo A subset of olfactory neurons that selectively express cGMP-stimulated phosphodiesterase (PDE2) and guanylyl cyclase-D define a unique olfactory signal transduction pathway Proc Natl Acad Sci U S A 94 1997 3388 3395
144. 2+ channels by beta-adrenergic agonists Proc Natl Acad Sci U S A 93 1996 295 299
145. N. Kajimura, M. Yamazaki, K. Morikawa, A. Yamazaki, and K. Mayanagi Three-dimensional structure of non-activated cGMP phosphodiesterase 6 and comparison of its image with those of activated forms J Struct Biol 139 2002 27 38
146. S. Kakiuchi, and R. Yamazaki Calcium dependent phosphodiesterase activity and its activating factor (PAF) from brain studies on cyclic 3′,5′-nucleotide phosphodiesterase (3) Biochem Biophys Res Commun 41 1970 1104 1110
147. R. Kakkar, R.V. Raju, and R.K. Sharma Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) Cell Mol Life Sci 55 1999 1164 1186
148. J.F. Kameni-Tcheudji, L. Lebeau, N. Virmaux, C.G. Maftei, R.H. Cote, and C. Lugnier Molecular organization of bovine rod cGMP-phosphodiesterase 6 J Mol Biol 310 2001 781 791
149. N. Kanda, and S. Watanabe Regulatory roles of adenylate cyclase and cyclic nucleotide phosphodiesterases 1 and 4 in interleukin-13 production by activated human T cells Biochem Pharmacol 62 2001 495 507
150. U.B. Kaupp, and R. Seifert Cyclic nucleotide-gated ion channels Physiol Rev 82 2002 769 824
151. S.L. Keely, and J.D. Corbin Involvement of cAMP-dependent protein kinase regulation of heart contractile force Am J Physiol 233 1977 H269 H275
152. T. Keravis, N. Komas, and C. Lugnier Cyclic nucleotide hydrolysis in bovine aortic endothelial cells in culture: differential regulation in cobblestone and spindle phenotypes J Vasc Res 37 2000 235 249
153. T. Kessler, and C. Lugnier Rolipram increases cyclic GMP content in l-arginine-treated cultured bovine aortic endothelial cells Eur J Pharmacol 290 1995 163 167
154. D. Kim, S.D. Rybalkin, X. Pi, Y. Wang, C. Zhang, and T. Munzel Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance Circulation 104 2001 2338 2343
155. M. Kimura, Y. Higashi, K. Hara, K. Noma, S. Sasaki, and K. Nakagawa PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers Hypertension 41 2003 1106 1110
156. T. Kitamura, Y. Kitamura, S. Kuroda, Y. Hino, M. Ando, and K. Kotani Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt Mol Cell Biol 19 1999 6286 6296
157. T. Kobayashi, M. Gamanuma, T. Sasaki, Y. Yamashita, K. Yuasa, and J. Kotera Molecular comparison of rat cyclic nucleotide phosphodiesterase 8 family: unique expression of PDE8B in rat brain Gene 319 2003 21 31
158. N. Komas, C. Lugnier, A. Le Bec, C. Serradeil-Le Gal, G. Barthelemy, and J.C. Stoclet Differential sensitivity to cardiotonic drugs of cyclic AMP phosphodiesterases isolated from canine ventricular and sinoatrial-enriched tissues J Cardiovasc Pharmacol 14 1989 213 220
159. N. Komas, A. Le Bec, J.C. Stoclet, and C. Lugnier Cardiac cGMP-stimulated cyclic nucleotide phosphodiesterases: effects of cGMP analogues and drugs Eur J Pharmacol 206 1991 5 13
160. N. Komas, C. Lugnier, and J.C. Stoclet Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors Br J Pharmacol 104 1991 495 503
161. J. Kotera, K. Fujishige, H. Akatsuka, Y. Imai, N. Yanaka, and K. Omori Novel alternative splice variants of cGMP-binding cGMP-specific phosphodiesterase J Biol Chem 273 1998 26982 26990
162. J. Kotera, K. Fujishige, K. Yuasa, and K. Omori Characterization and phosphorylation of PDE10A2, a novel alternative splice variant of human phosphodiesterase that hydrolyzes cAMP and cGMP Biochem Biophys Res Commun 261 1999 551 557
163. J. Kotera, T. Sasaki, T. Kobayashi, K. Fujishige, Y. Yamashita, and K. Omori Subcellular localization of cyclic nucleotide phosphodiesterase type 10A variants, and alteration of the localization by cAMP-dependent protein kinase-dependent phosphorylation J Biol Chem 279 2004 4366 4375
164. M. Koyanagi, H. Suga, D. Hoshiyama, K. Ono, N. Iwabe, and K. Kuma Ancient gene duplication and domain shuffling in the animal cyclic nucleotide phosphodiesterase family FEBS Lett 436 1998 323 328
165. W.R. Kukovetz, and G. Poch Inhibition of cyclic-3′,5′- nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs Naunyn Schmiedebergs Arch Pharmacol 267 1970 189 194
166. A. Kurtz, K.H. Gotz, M. Hamann, and C. Wagner Stimulation of renin secretion by nitric oxide is mediated by phosphodiesterase 3 Proc Natl Acad Sci U S A 95 1998 4743 4747
167. F. Laliberté, Y. Han, A. Govindarajan, A. Giroux, S. Liu, and B. Bobechko Conformational difference between PDE4 apoenzyme and holoenzyme Biochemistry 39 2000 6449 6458
168. M.E. Lee, J. Markowitz, J.O. Lee, and H. Lee Crystal structure of phosphodiesterase 4D and inhibitor complex(1) FEBS Lett 530 2002 53 58
169. R. Lee, S. Wolda, E. Moon, J. Esselstyn, C. Hertel, and A. Lerner PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP Cell Signal 14 2002 277 284
170. L. Lefièvre, E. de Lamirande, and C. Gagnon Presence of cyclic nucleotide phosphodiesterases PDE1A, existing as a stable complex with calmodulin, and PDE3A in human spermatozoa Biol Reprod 67 2002 423 430
171. T.S. Li, K. Volpp, and M.L. Applebury Bovine cone photoreceptor cGMP phosphodiesterase structure deduced from a cDNA clone Proc Natl Acad Sci U S A 87 1990 293 297
172. N. Li, S.K. Florio, M.J. Pettenati, P.N. Rao, J.A. Beavo, and W. Baehr Characterization of human and mouse rod cGMP phosphodiesterase delta subunit (PDE6D) and chromosomal localization of the human gene Genomics 49 1998 76 82
173. L. Li, C. Yee, and J.A. Beavo CD3- and CD28-dependent induction of PDE7 required for T cell activation Science 283 1999 848 851
174. C.S. Lin, S. Chow, A. Lau, R. Tu, and T.F. Lue Regulation of human PDE5A2 intronic promoter by cAMP and cGMP: identification of a critical Sp1-binding site Biochem Biophys Res Commun 280 2001 693 699
175. C.S. Lin, S. Chow, A. Lau, R. Tu, and T.F. Lue Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters Int J Impot Res 14 2002 15 24
176. G. Lin, Z.C. Xin, T.F. Lue, and C.S. Lin Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism J Urol 170 2003 S15 S18
177. V.M. Lipkin, N.V. Khramtsov, I.A. Vasilevskaya, N.V. Atabekova, K.G. Muradov, and V.V. Gubanov Beta-subunit of bovine rod photoreceptor cGMP phosphodiesterase. Comparison with the phosphodiesterase family J Biol Chem 265 1990 12955 12959
178. H. Liu, and D.H. Maurice Phosphorylation-mediated activation and translocation of the cyclic AMP-specific phosphodiesterase PDE4D3 by cyclic AMP-dependent protein kinase and mitogen-activated protein kinases. A potential mechanism allowing for the coordinated regulation of PDE4D activity and targeting J Biol Chem 274 1999 10557 10565
179. S. Liu, F. Laliberté, B. Bobechko, A. Bartlett, P. Lario, and E. Gorseth Dissecting the cofactor-dependent and independent bindings of PDE4 inhibitors Biochemistry 40 2001 10179 10186
180. Y. Liu, Y. Shakur, M. Yoshitake, and J. Ji Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake Cardiovasc Drug Rev 19 2001 369 386
181. m, rolipram-sensitive cyclic AMP phosphodiesterase Mol Cell Biol 10 1990 2678 2686
182. A. Lochhead, E. Nekrasova, V.Y. Arshavsky, and N.J. Pyne The regulation of the cGMP-binding cGMP phosphodiesterase proteins that are immunologically related to gamma subunit of the photoreceptor cGMP phosphodiesterase J Biol Chem 272 1997 18397 18403
183. K. Loughney, T.J. Martins, E.A. Harris, K. Sadhu, J.B. Hicks, and W.K. Sonnenburg Isolation and characterization of cDNAs corresponding to two human calcium, calmodulin-regulated, 3′,5′-cyclic nucleotide phosphodiesterases J Biol Chem 271 1996 796 806
184. K. Loughney, T.R. Hil, V.A. Florio, L. Uher, G.J. Rosman, and S.L. Wolda Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase Gene 216 1998 139 147
185. K. Loughney, P.B. Snyder, L. Uher, G.J. Rosman, K. Ferguson, and V.A. Florio Isolation and characterization of PDE10A, a novel human 3′, 5′-cyclic nucleotide Gene 234 1999 109 117
186. C. Lugnier Phosphodiesterase methods and protocols J.M. Walker Methods and Molecular Biology Series vol. 307 2005 Humana Press Totowa, NJ
187. C. Lugnier, and N. Komas Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation Eur Heart J 14 1993 141 148
188. C. Lugnier, and V.B. Schini Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells Biochem Pharmacol 39 1990 75 84
189. C. Lugnier, Y. Bertrand, and J.C. Stoclet Cyclic nucleotide phosphodiesterase inhibition and vascular smooth muscle relaxation Eur J Pharmacol 19 1972 134 136
190. C. Lugnier, A. Stierle, A. Beretz, P. Schoeffter, A. Le Bec, and C.G. Wermuth Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activity Biochem Biophys Res Commun 113 1983 954 959
191. C. Lugnier, A. Follenius, D. Gerard, and J.C. Stoclet Bepridil and flunarizine as calmodulin inhibitors Eur J Pharmacol 98 1984 157 158
192. C. Lugnier, P. Schoeffter, A. Le Bec, E. Strouthou, and J.C. Stoclet Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta Biochem Pharmacol 35 1986 1743 1751
193. C. Lugnier, C. Gauthier, A. Le Bec, and H. Soustre Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities Am J Physiol 262 1992 H654 H660
194. C. Lugnier, B. Muller, A. Le Bec, C. Beaudry, and E. Rousseau Characterization of indolidan- and rolipram-sensitive cyclic nucleotide phosphodiesterases in canine and human cardiac microsomal fractions J Pharmacol Exp Ther 265 1993 1142 1151
195. C. Lugnier, T. Keravis, and A. Eckly-Michel Cross talk between NO and cyclic nucleotide phosphodiesterases in the modulation of signal transduction in blood vessel J Physiol Pharmacol 50 1999 639 652
196. C. Lugnier, T. Keravis, A. Le Bec, O. Pauvert, S. Proteau, and E. Rousseau Characterization of cyclic nucleotide phosphodiesterase isoforms associated to isolated cardiac nuclei Biochim Biophys Acta 1472 1999 431 446
197. R.T. MacFarland, B.D. Zelus, and J.A. Beavo High concentrations of a cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells J Biol Chem 266 1991 136 142
198. S.J. MacKenzie, G.S. Baillie, I. McPhee, G.B. Bolger, and M.D. Houslay ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regions J Biol Chem 275 2000 16609 16617
199. m cAMP phosphodiesterase: probable target for anti-thrombotic agents Proc Natl Acad Sci U S A 83 1986 6660 6663
200. V.C. Manganiello, T. Tanaka, and S. Murashima Cyclic-GMP-stimulated cyclic nucleotide phosphodiesterases J. Beavo M.D. Houslay Cyclic Nucleotide Phosphodiesterases: Structure, Regulation and Drug Action 1990 John Wiley and Sons Ltd. 61 85
201. C.D. Manning, M.M. McLaughlin, G.P. Livi, L.B. Cieslinski, T.J. Torphy, and M.S. Barnette Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B J Pharmacol Exp Ther 276 1996 810 818
202. C.D. Manning, M. Burman, S.B. Christensen, L.B. Cieslinski, D.M. Essayan, and M. Grous Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B Br J Pharmacol 128 1999 1393 1398
203. M.C. Marivet, J.J. Bourguignon, C. Lugnier, A. Mann, J.C. Stoclet, and C.G. Wermuth Inhibition of cyclic adenosine-3′,5′-monophosphate phosphodiesterase from vascular smooth muscle by rolipram analogues J Med Chem 32 1989 1450 1457
204. W. Martin, R.F. Furchgott, G.M. Villani, and D. Jothianandan Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor J Pharmacol Exp Ther 237 1986 539 547
205. S.E. Martinez, A.Y. Wu, N.A. Glavas, X.B. Tang, S. Turley, and W.G. Hol The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding Proc Natl Acad Sci U S A 99 2002 13260 13265
206. T.J. Martins, M.C. Mumby, and J.A. Beavo Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues J Biol Chem 257 1982 1973 1979
207. S. Masciarelli, K. Horner, C. Liu, S.H. Park, M. Hinckley, and S. Hockman Cyclic nucleotide phosphodiesterase 3A-deficient mice as a model of female infertility J Clin Invest 114 2004 196 205
208. M. Mata, B. Sarria, A. Buenestado, J. Cortijo, M. Cerda, and E.J. Morcillo Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells Thorax 60 2005 144 152
209. K. Matulef, and W.N. Zagotta Cyclic nucleotide-gated ion channels Annu Rev Cell Dev Biol 19 2003 23 44
210. D.H. Maurice, and R.J. Haslam Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP Mol Pharmacol 37 1990 671 681
211. C.R. Maxwell, S.J. Kanes, T. Abel, and S.J. Siegel Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications Neuroscience 129 2004 101 107
212. L.M. McAllister-Lucas, W.K. Sonnenburg, A. Kadlecek, D. Seger, H.L. Trong, and J.L. Colbran The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone J Biol Chem 268 1993 22863 22873
213. m, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. Cloning and expression of cDNA, biochemical characterization of recombinant protein, and tissue distribution of mRNA J Biol Chem 268 1993 6470 6476
214. I. McPhee, S.J. Yarwood, G. Scotland, E. Huston, M.B. Beard, and A.H. Ross Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B. Consequences for rolipram inhibition J Biol Chem 274 1999 11796 11810
215. E. Meacci, M. Taira, M. Moos Jr., C.J. Smith, M.A. Movsesian, and E. Degerman Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase Proc Natl Acad Sci U S A 89 1992 3721 3725
216. C. Mehats, C.B. Andersen, M. Filopanti, S.L. Jin, and M. Conti Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling Trends Endocrinol Metab 13 2002 29 35
217. P.F. Mery, C. Pavoine, F. Pecker, and R. Fischmeister Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes Mol Pharmacol 48 1995 121 130
218. M.R. Meyer, A. Angele, E. Kremmer, U.B. Kaupp, and F. Muller A cGMP-signaling pathway in a subset of olfactory sensory neurons Proc Natl Acad Sci U S A 97 2000 10595 10600
219. T. Michaeli, T.J. Bloom, T. Martins, K. Loughney, K. Ferguson, and M. Riggs Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae J Biol Chem 268 1993 12925 12932
220. 2+/calmodulin dependent phosphodiesterase PDE1A: novel splice variants, their specific expression, genomic organization, and chromosomal localization Biochim Biophys Acta 1517 2001 278 287
221. N. Miki, J.M. Baraban, J.J. Keirns, J.J. Boyce, and M.W. Bitensky Purification and properties of the light-activated cyclic nucleotide phosphodiesterase of rod outer segments J Biol Chem 250 1975 6320 6327
222. T. Miki, M. Taira, S. Hockman, F. Shimada, J. Lieman, and M. Napolitano Characterization of the cDNA and gene encoding human PDE3B, the cGIP1 isoform of the human cyclic GMP-inhibited cyclic nucleotide phosphodiesterase family Genomics 36 1996 476 485
223. F. Miot, P.J. Van Haastert, and C. Erneux Specificity of cGMP binding to a purified cGMP-stimulated phosphodiesterase from bovine adrenal tissue Eur J Biochem 149 1985 59 65
224. X. Miro, J.M. Casacuberta, M.D. Gutierrez-Lopez, M.O. de Landazuri, and P. Puigdomenech Phosphodiesterases 4D and 7A splice variants in the response of HUVEC cells to TNF-alpha Biochem Biophys Res Commun 274 2000 415 421
225. X. Miro, S. Perez-Torres, J.M. Palacios, P. Puigdomenech, and G. Mengod Differential distribution of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs Synapse 40 2001 201 214
226. X. Miro, S. Perez-Torres, F. Artigas, P. Puigdomenech, J.M. Palacios, and G. Mengod Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study Neuropharmacology 43 2002 1148 1157
227. M. Miyahara, M. Ito, H. Itoh, T. Shiraishi, N. Isaka, and T. Konishi Isoenzymes of cyclic nucleotide phosphodiesterase in the human aorta: characterization and the effects of E4021 Eur J Pharmacol 284 1995 25 33
228. M. Mongillo, T. McSorley, S. Evellin, A. Sood, V. Lissandron, and A. Terrin Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases Circ Res 95 2004 67 75
229. E.Y. Moon, and A. Lerner PDE4 inhibitors activate a mitochondrial apoptotic pathway in chronic lymphocytic leukemia cells that is regulated by protein phosphatase 2A Blood 101 2003 4122 4130
230. W.H. Moos, C.C. Humblet, I. Sircar, C. Rithner, R.E. Weishaar, and J.A. Bristol Cardiotonic agents: 8. Selective inhibitors of adenosine 3′,5′-cyclic phosphate phosphodiesterase III. Elaboration of a five-point model for positive inotropic activity J Med Chem 30 1987 1963 1972
231. F. Morin, C. Lugnier, J. Kameni, and P. Voisin Expression and role of phosphodiesterase 6 in the chicken pineal gland J Neurochem 78 2001 88 99
232. H. Mou, H.J. Grazio 3rd, T.A. Cook, J.A. Beavo, and R.H. Cote cGMP binding to noncatalytic sites on mammalian rod photoreceptor phosphodiesterase is regulated by binding of its gamma and delta subunits J Biol Chem 274 1999 18813 18820
233. B. Muller, C. Lugnier, and J.C. Stoclet Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction J Cardiovasc Pharmacol 16 1990 796 803
234. B. Muller, C. Lugnier, and J.C. Stoclet Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria J Cardiovasc Pharmacol 15 1990 444 451
235. B. Muller, J.C. Stoclet, and C. Lugnier Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles Eur J Pharmacol 225 1992 263 272
236. T. Muller, P. Engels, and J.R. Fozard Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition Trends Pharmacol Sci 17 1996 294 298
237. F. Mullershausen, A. Friebe, R. Feil, W.J. Thompson, F. Hofmann, and D. Koesling Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling J Cell Biol 160 2003 719 727
238. H. Muradov, K.K. Boyd, and N.O. Artemyev Structural determinants of the PDE6 GAF A domain for binding the inhibitory gamma-subunit and noncatalytic cGMP Vision Res 44 2004 2437 2444
239. S. Murashima, T. Tanaka, S. Hockman, and V. Manganiello Characterization of particulate cyclic nucleotide phosphodiesterases from bovine brain: purification of a distinct cGMP-stimulated isoenzyme Biochemistry 29 1990 5285 5292
240. G. Nemoz, C. Sette, and M. Conti Selective activation of rolipram-sensitive, cAMP-specific phosphodiesterase isoforms by phosphatidic acid Mol Pharmacol 51 1997 242 249
241. E. Nikulina, J.L. Tidwell, H.N. Dai, B.S. Bregman, and M.T. Filbin The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery Proc Natl Acad Sci U S A 101 2004 8786 8790
242. 2+ sources Naunyn Schmiedebergs Arch Pharmacol 363 2001 612 619
243. P. Nokin, J.P. Blondiaux, P. Schaeffer, L. Jungblut, and C. Lugnier Amiodarone is a potent calmodulin antagonist Naunyn Schmiedebergs Arch Pharmacol 339 1989 367 373
244. A.W. Norton, M.R. D'Amours, H.J. Grazio, T.L. Hebert, and R.H. Cote Mechanism of transducin activation of frog rod photoreceptor phosphodiesterase. Allosteric interactions between the inhibitory gamma subunit and the noncatalytic cGMP-binding sites J Biol Chem 275 2000 38611 38619
245. V. O'Connor, A. Genin, S. Davis, K.K. Karishma, V. Doyere, and C.I. De Zeeuw Differential amplification of intron-containing transcripts reveals long term potentiation-associated up-regulation of specific PDE10A phosphodiesterase splice variants J Biol Chem 279 2004 15841 15849
246. R. Obernolte, S. Bhakta, R. Alvarez, C. Bach, P. Zuppan, and M. Mulkins The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene family Gene 129 1993 239 247
247. S. Oger, C. Mehats, E. Dallot, F. Ferre, and M.J. Leroy Interleukin-1beta induces phosphodiesterase 4B2 expression in human myometrial cells through a prostaglandin E2- and cyclic adenosine 3′,5′-monophosphate-dependent pathway J Clin Endocrinol Metab 87 2002 5524 5531
248. N. Oki, S.I. Takahashi, H. Hidaka, and M. Conti Short term feedback regulation of cAMP in FRTL-5 thyroid cells. Role of PDE4D3 phosphodiesterase activation J Biol Chem 275 2000 10831 10837
249. L. Okruhlicova, N. Tribulova, A. Eckly, C. Lugnier, and J. Slezak Cytochemical distribution of cyclic AMP-dependent 3′,5′-nucleotide phosphodiesterase in the rat myocardium Histochem J 28 1996 165 172
250. L. Okruhlicova, N. Tribulova, J. Styk, A. Eckly, C. Lugnier, and J. Slezak Species differences in localization of cardiac cAMP-phosphodiesterase activity: a cytochemical study Mol Cell Biochem 173 1997 183 188
251. L. Okruhlicova, N. Vrbjar, and C. Lugnier Characterization of type 4 cyclic nucleotide phosphodiesterase (PDE4) in cardiac sarcolemma Exp Clin Cardiol 3 1998 188 192
252. A. Onody, A. Zvara, L. Hackler Jr., L. Vigh, P. Ferdinandy, and L.G. Puskas Effect of classic preconditioning on the gene expression pattern of rat hearts: a DNA microarray study FEBS Lett 536 2003 35 40
253. H. Osawa, T. Niiya, H. Onuma, A. Murakami, M. Ochi, and T. Nishimiya Systematic search for single nucleotide polymorphisms in the 5′ flanking region of the human phosphodiesterase 3B gene: absence of evidence for major effects of identified polymorphisms on susceptibility to Japanese type 2 diabetes Mol Genet Metab 79 2003 43 45
254. Yu.A. Ovchinnikov, V.V. Gubanov, N.V. Khramtsov, K.A. Ischenko, V.E. Zagranichny, and K.G. Muradov Cyclic GMP phosphodiesterase from bovine retina. Amino acid sequence of the alpha-subunit and nucleotide sequence of the corresponding cDNA FEBS Lett 223 1987 169 173
255. Yu.A. Ovchinnikov, V.M. Lipkin, V.P. Kumarev, V.V. Gubanov, N.V. Khramtsov, and N.B. Akhmedov Cyclic GMP phosphodiesterase from cattle retina. Amino acid sequence of the gamma-subunit and nucleotide sequence of the corresponding cDNA FEBS Lett 204 1986 288 292
256. R.J. Owens, S. Lumb, K. Rees-Milton, A. Russell, D. Baldock, and V. Lang Molecular cloning and expression of a human phosphodiesterase 4C Cell Signal 9 1997 575 585
257. O. Pauvert, D. Salvail, E. Rousseau, C. Lugnier, R. Marthan, and J.P. Savineau Characterisation of cyclic nucleotide phosphodiesterase isoforms in the media layer of the main pulmonary artery Biochem Pharmacol 63 2002 1763 1772
258. O. Pauvert, C. Lugnier, T. Keravis, R. Marthan, E. Rousseau, and J.P. Savineau Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery Br J Pharmacol 139 2003 513 522
259. M.J. Perry, J. O'Connell, C. Walker, T. Crabbe, D. Baldock, and A. Russell CDP840: a novel inhibitor of PDE-4 Cell Biochem Biophys 29 1998 113 132
260. N.I. Piriev, A.S. Viczian, J. Ye, B. Kerner, J.R. Korenberg, and D.B. Farber Gene structure and amino acid sequence of the human cone photoreceptor cGMP-phosphodiesterase alpha' subunit (PDEA2) and its chromosomal localization to 10q24 Genomics 28 1995 429 435
261. T. Podzuweit, A. Müller, and P. Nennstiel Selective inhibition of the cGMP stimulated cyclic nucleotide phosphodiesterase from pig and human myocardium J Mol Cell Cardiol 24 1992 S.102
262. T. Podzuweit, P. Nennstiel, and A. Muller Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3- nonyl) adenine Cell Signal 7 1995 733 738
263. J.W. Polli, and R.L. Kincaid Molecular cloning of DNA encoding a calmodulin-dependent phosphodiesterase enriched in striatum Proc Natl Acad Sci U S A 89 1992 11079 11083
264. J. Prickaerts, A. Sik, W.C. van Staveren, G. Koopmans, H.W. Steinbusch, and F.J. van der Staay Phosphodiesterase type 5 inhibition improves early memory consolidation of object information Neurochem Int 45 2004 915 928
265. E.N. Pugh Jr., and T.D. Lamb Phototransduction in vertebrate rods and cones: molecular mechanism of amplification, recovery and light adaptation Molecular Mechanisms in Visual Transduction 2000 183 255
266. N.J. Pyne, M.E. Cooper, and M.D. Houslay Identification and characterization of both the cytosolic and particulate forms of cyclic GMP-stimulated cyclic AMP phosphodiesterase from rat liver Biochem J 234 1986 325 334
267. P. Raboisson, C. Lugnier, C. Muller, J.M. Reimund, D. Schultz, and G. Pinna Design, synthesis and structure-activity relationships of a series of 9-substituted adenine derivatives as selective phosphodiesterase type-4 inhibitors Eur J Med Chem 38 2003 199 214
268. T. Rahn, L. Ronnstrand, M.J. Leroy, C. Wernstedt, H. Tornqvist, and V.C. Manganiello Identification of the site in the cGMP-inhibited phosphodiesterase phosphorylated in adipocytes in response to insulin and isoproterenol J Biol Chem 271 1996 11575 11580
269. R.M. Rapoport, and F. Murad Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP J Cyclic Nucleotide Protein Phosphor Res 9 1983 281 296
270. T.M. Reed, D.R. Repaske, G.L. Snyder, P. Greengard, and C.V. Vorhees Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning J Neurosci 22 2002 5188 5197
271. M.L. Reeves, B.K. Leigh, and P.J. England The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors Biochem J 241 1987 535 541
272. J.M. Reimund, P. Raboisson, G. Pinna, C. Lugnier, J.J. Bourguignon, and C.D. Muller Anti-TNF-alpha properties of new 9-benzyladenine derivatives with selective phosphodiesterase-4-inhibiting properties Biochem Biophys Res Commun 288 2001 427 434
273. C. Rentero, A. Monfort, and P. Puigdomenech Identification and distribution of different mRNA variants produced by differential splicing in the human phosphodiesterase 9A gene Biochem Biophys Res Commun 301 2003 686 692
274. W. Richter, and M. Conti The oligomerization state determines regulatory properties and inhibitor sensitivity of type 4 cAMP-specific phosphodiesterases J Biol Chem 279 2004 30338 30348
275. M. Rivet-Bastide, G. Vandecasteele, S. Hatem, I. Verde, A. Benardeau, and J.J. Mercadier cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes J Clin Invest 99 1997 2710 2718
276. A. Robichaud, P.B. Stamatiou, S.L. Jin, N. Lachance, D. MacDonald, and F. Laliberté Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis J Clin Invest 110 2002 1045 1052
277. F. Rochais, G. Vandecasteele, F. Lefebvre, C. Lugnier, H. Lum, and J.L. Mazet Negative feedback exerted by cAMP-dependent protein kinase and cAMP phosphodiesterase on subsarcolemmal cAMP signals in intact cardiac myocytes: an in vivo study using adenovirus-mediated expression of CNG channels J Biol Chem 279 2004 52095 520105
278. W.J. Rocque, G. Tian, J.S. Wiseman, W.D. Holmes, I. Zajac-Thompson, and D.H. Willard Human recombinant phosphodiesterase 4B2B binds (R)-rolipram at a single site with two affinities Biochemistry 36 1997 14250 14261
279. C.M. Rondinone, E. Carvalho, T. Rahn, V.C. Manganiello, E. Degerman, and U.P. Smith Phosphorylation of PDE3B by phosphatidylinositol 3-kinase associated with the insulin receptor J Biol Chem 275 2000 10093 10098
280. G.J. Rosman, T.J. Martins, W.K. Sonnenburg, J.A. Beavo, K. Ferguson, and K. Loughney Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3′,5′-cyclic nucleotide phosphodiesterase Gene 191 1997 89 95
281. D. Ruppert, and K.U. Weithmann HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro Life Sci 31 1982 2037 2043
282. S.D. Rybalkin, I. Rybalkina, J.A. Beavo, and K.E. Bornfeldt Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation Circ Res 90 2002 151 157
283. S.D. Rybalkin, I.G. Rybalkina, M. Shimizu-Albergine, X.B. Tang, and J.A. Beavo PDE5 is converted to an activated state upon cGMP binding to the GAF A domain EMBO J 22 2003 469 478
284. K. Sadhu, K. Hensley, V.A. Florio, and S.L. Wolda Differential expression of the cyclic GMP-stimulated phosphodiesterase PDE2A in human venous and capillary endothelial cells J Histochem Cytochem 47 1999 895 906
285. T. Saeki, H. Adachi, Y. Takase, S. Yoshitake, S. Souda, and I. Saito A selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery J Pharmacol Exp Ther 272 1995 825 831
286. J. Sarfati, M. Diaquin, J.P. Debeaupuis, A. Schmidt, D. Lecaque, and A. Beauvais Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells Blood 101 2003 265 269
287. T. Sasaki, J. Kotera, K. Yuasa, and K. Omori Identification of human PDE7B, a cAMP-specific phosphodiesterase Biochem Biophys Res Commun 271 2000 575 583
288. T. Sasaki, J. Kotera, and K. Omori Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation Biochem J 361 2002 211 220
289. T. Sasaki, J. Kotera, and K. Omori Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons J Neurochem 9 2004 474 483
290. G. Scapin, S.B. Patel, C. Chung, J.P. Varnerin, S.D. Edmondson, and A. Mastracchio Crystal structure of human phosphodiesterase 3B: atomic basis for substrate and inhibitor specificity Biochemistry 43 2004 6091 6100
291. H.H. Schneider, R. Schmiechen, M. Brezinski, and J. Seidler Stereospecific binding of the antidepressant rolipram to brain protein structures Eur J Pharmacol 127 1986 105 115
292. P. Schoeffter, C. Lugnier, F. Demesy-Waeldele, and J.C. Stoclet Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors Biochem Pharmacol 36 1987 3965 3972
293. S. Schrofner, A. Zsombok, A. Hermann, and H.H. Kerschbaum Nitric oxide decreases a calcium-activated potassium current via activation of phosphodiesterase 2 in helix U-cells Brain Res 999 2004 98 105
294. U. Schwabe, M. Miyake, Y. Ohga, and J.W. Daly 4-(3-Cyclopentyloxy-4 methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3′,5′-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain Mol Pharmacol 12 1976 900 910
295. A. Sebkhi, J.W. Strange, S.C. Phillips, J. Wharton, and M.R. Wilkins Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension Circulation 107 2003 3230 3235
296. P. Secchiero, D. Zella, S. Curreli, P. Mirandola, S. Capitani, and R.C. Gallo Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4 + T cell hyperactivation and HIV type 1 replication Proc Natl Acad Sci U S A 97 2000 14620 14625
297. H. Senzaki, C.H. Chen, S. Masutani, M. Taketazu, J. Kobayashi, and T. Kobayashi Assessment of cardiovascular dynamics by pressure-area relations in pediatric patients with congenital heart disease J Thorac Cardiovasc Surg 122 2001 535 547
298. C. Sette, S. Iona, and M. Conti The short-term activation of a rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation J Biol Chem 269 1994 9245 9252
299. J. Seybold, D. Thomas, M. Witzenrath, S. Boral, A.C. Hocke, and A. Burger Tumor necrosis factor-α dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability Blood 105 2005 3569 3576
300. R.K. Sharma Phosphorylation and characterization of bovine heart calmodulin-dependent phosphodiesterase Biochemistry 30 1991 5963 5968
301. R.K. Sharma, and J.H. Wang Differential regulation of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isoenzymes by cyclic AMP-dependent protein kinase and calmodulin-dependent phosphatase Proc Natl Acad Sci U S A 82 1985 2603 2607
302. 2+-dependent phosphorylation and dephosphorylation of 63-kDa subunit-containing bovine brain calmodulin-stimulated cyclic nucleotide phosphodiesterase isozyme J Biol Chem 261 1986 1322 1328
303. A. Shimizu-Matsumoto, K. Itoh, J. Inazawa, K. Nishida, Y. Matsumoto, and S. Kinoshita Isolation and chromosomal localization of the human cone cGMP phosphodiesterase gamma cDNA (PDE6H) Genomics 32 1996 121 124
304. K. Shitsukawa, C.B. Andersen, F.J. Richard, A.K. Horner, A. Wiersma, and M. van Duin Cloning and characterization of the cyclic guanosine monophosphate-inhibited phosphodiesterase PDE3A expressed in mouse oocyte Biol Reprod 65 2001 188 196
305. S.J. Smith, S. Brookes-Fazakerley, L.E. Donnelly, P.J. Barnes, M.S. Barnette, and M.A. Giembycz Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells Am J Physiol Lung Cell Mol Physiol 284 2003 L279 L289
306. S.J. Smith, L.B. Cieslinski, R. Newton, L.E. Donnelly, P.S. Fenwick, and A.G. Nicholson Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl- nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages, and CD8 + T-lymphocytes Mol Pharmacol 66 2004 1679 1689
307. P.B. Snyder, J.M. Esselstyn, K. Loughney, S.L. Wolda, and V.A. Florio The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis J Lipid Res 46 2005 494 503
308. S.H. Soderling, and J.A. Beavo Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions Curr Opin Cell Biol 12 2000 174 179
309. S.H. Soderling, S.J. Bayuga, and J.A. Beavo Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases J Biol Chem 273 1998 15553 15558
310. S.H. Soderling, S.J. Bayuga, and J.A. Beavo Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase Proc Natl Acad Sci U S A 95 1998 8991 8996
311. S.H. Soderling, S.J. Bayuga, and J.A. Beavo Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A Proc Natl Acad Sci U S A 96 1999 7071 7076
312. W.K. Sonnenburg, P.J. Mullaney, and J.A. Beavo Molecular cloning of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase cDNA. Identification and distribution of isozyme variants J Biol Chem 266 1991 17655 17661
313. W.K. Sonnenburg, D. Seger, K.S. Kwak, J. Huang, H. Charbonneau, and J.A. Beavo Identification of inhibitory and calmodulin-binding domains of the PDE1A1 and PDE1A2 calmodulin-stimulated cyclic nucleotide phosphodiesterases J Biol Chem 270 1995 30989 31000
314. S. Sopory, S. Balaji, N. Srinivasan, and S.S. Visweswariah Modeling and mutational analysis of the GAF domain of the cGMP-binding, cGMP-specific phosphodiesterase, PDE5 FEBS Lett 539 2003 161 166
315. J.E. Souness, and S. Rao Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases Cell Signal 9 1997 227 236
316. J.E. Souness, R. Brazdil, B.K. Diocee, and R. Jordan Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine Br J Pharmacol 98 1989 725 734
317. J.E. Souness, C. Maslen, S. Webber, M. Foster, D. Raeburn, and M.N. Palfreyman Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram Br J Pharmacol 115 1995 39 46
318. S. Spence, G. Rena, M. Sullivan, S. Erdogan, and M.D. Houslay Receptor-mediated stimulation of lipid signalling pathways in CHO cells elicits the rapid transient induction of the PDE1B isoform of Ca2+/calmodulin-stimulated cAMP phosphodiesterase Biochem J 321 1997 157 163
319. J.C. Stoclet, T. Keravis, N. Komas, and C. Lugnier Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiovascular diseases Expert Opin Investig Drugs 4 1995 1081 1100
320. L. Stryer Vision: from photon to perception Proc Natl Acad Sci U S A 93 1996 557 559
321. T. Sudo, K. Tachibana, K. Toga, S. Tochizawa, Y. Inoue, and Y. Kimura Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity Biochem Pharmacol 59 2000 347 356
322. M. Sullivan, M. Egerton, Y. Shakur, A. Marquardsen, and M.D. Houslay Molecular cloning and expression, in both COS-1 cells and S. cerevisiae, of a human cytosolic type-IVA, cyclic AMP specific phosphodiesterase (hPDE-IVA-h6.1) Cell Signal 6 1994 793 812
323. E.W. Sutherland, and T.W. Rall Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles J Biol Chem 232 1958 1077 1091
324. N. Suttorp, S. Hippenstiel, M. Fuhrmann, M. Krull, and T. Podzuweit Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability Am J Physiol 270 1996 C778 C785
325. J.V. Swinnen, D. Joseph, and R. Conti Molecular cloning of rat homologues of the Drosophila melanogaster dunce cAMP phosphodiesterase: evidence for a family of genes Proc Natl Acad Sci U S A 86 1989 5325 5329
326. J.V. Swinnen, K.E. Tsikalas, and M. Conti Properties and hormonal regulation of two structurally related cAMP phosphodiesterases from the rat Sertoli cell J Biol Chem 266 1991 18370 18377
327. M. Takami, E.S. Cho, S.Y. Lee, R. Kamijo, and M. Yim Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways FEBS Lett 579 2005 832 838
328. R.J. Tate, A. Lochhead, H. Brzeski, V. Arshavsky, and N.J. Pyne The gamma-subunit of the rod photoreceptor cGMP-binding cGMP-specific PDE is expressed in mouse lung Cell Biochem Biophys 29 1998 133 144
329. H. Tenor, and C. Schudt Analysis of PDE isoenzyme profiles in cells and tissues by pharmacological methods C. Schudt G. Dent K.F. Rabe Phosphodiesterase Inhibitors, Handbook of Immunopharmacology 1996 Academic Press 21 40
330. M.K. Thomas, S.H. Francis, and J.D. Corbin Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase J Biol Chem 265 1990 14964 14970
331. W.J. Thompson, and M.M. Appleman Characterization of cyclic nucleotide phosphodiesterases of rat tissues J Biol Chem 246 1971 3145 3150
332. T.J. Torphy, and B.J. Undem Phosphodiesterase inhibitors: new opportunities for the treatment of asthma Thorax 46 1991 512 523
333. T.J. Torphy, J.M. Stadel, M. Burman, L.B. Cieslinski, M.M. McLaughlin, and J.R. White Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast J Biol Chem 267 1992 1798 1804
334. T.J. Torphy, H.L. Zhou, J.J. Foley, H.M. Sarau, C.D. Manning, and M.S. Barnette Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonists J Biol Chem 270 1995 23598 235604
335. M. Torras-Llort, and F. Azorin Functional characterization of the human phosphodiesterase 7A1 promoter Biochem J 373 2003 835 843
336. T.J. Toward, F.J. Johnson, J.E. Boult, and J.Y. Maillard Airway function and reactivity, leukocyte influx and nitric oxide after inoculation with parainfluenza-3 virus: effects of dexamethasone or rolipram Int Immunopharmacol 5 2005 771 782
337. J. Tremblay, B. Lachance, and P. Hamet Activation of cyclic GMP-binding and cyclic AMP-specific phosphodiesterases of rat platelets by a mechanism involving cyclic AMP-dependent phosphorylation J Cyclic Nucleotide Protein Phosphor Res 10 1985 397 411
338. R.W. Tsien Cyclic AMP and contractile activity in heart Adv Cycl Nucleotide Res 8 1977 363 420
339. I.V. Turko, S.H. Francis, and J.D. Corbin Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation Biochem J 329 1998 505 510
340. I.P. Udovichenko, J. Cunnick, K. Gonzalez, A. Yakhnin, and D.J. Takemoto Protein kinase C in rod outer segments: effects of phosphorylation of the phosphodiesterase inhibitory subunit Biochem J 317 1996 291 295
341. W.C. Van Staveren, J. Glick, M. Markerink-van Ittersum, M. Shimizu, J.A. Beavo, and H.W. Steinbusch Cloning and localization of the cGMP-specific phosphodiesterase type 9 in the rat brain J Neurocytol 31 2002 729 741
342. W.C. Van Staveren, H.W. Steinbusch, M. Markerink-Van Ittersum, D.R. Repaske, M.F. Goy, and J. Kotera mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain J Comp Neurol 467 2003 566 580
343. W.C. Van Staveren, H.W. Steinbusch, M. Markerink-van Ittersum, S. Behrends, and J. de Vente Species differences in the localization of cGMP-producing and NO-responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry Eur J Neurosci 19 2004 2155 2168
344. G. Vandecasteele, I. Verde, C. Rucker-Martin, P. Donzeau-Gouge, and R. Fischmeister Cyclic GMP regulation of the L-type Ca(2+) channel current in human atrial myocytes J Physiol 533 2001 329 340
345. S. Vemulapalli, R.W. Watkins, M. Chintala, H. Davis, H.S. Ahn, and A. Fawzi Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitor J Cardiovasc Pharmacol 28 1996 862 869
346. I. Verde, G. Pahlke, M. Salanova, G. Zhang, S. Wang, and D. Coletti Myomegalin is a novel protein of the Golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase J Biol Chem 276 2001 11189 11198
347. F. Vergne, P. Bernardelli, E. Lorthiois, N. Pham, E. Proust, and C. Oliveira Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors: Part 2. Metabolism-directed optimization studies towards orally bioavailable derivatives Bioorg Med Chem Lett 14 2004 4615 4621
348. N.K. Vo, J.M. Gettemy, and V.M. Coghlan Identification of cGMP-dependent protein kinase anchoring proteins (GKAPs) Biochem Biophys Res Commun 246 1998 831 835
349. Y. Waki, T. Horita, K. Miyamoto, K. Ohya, and S. Kasugai Effects of XT-44, a phosphodiesterase 4 inhibitor, in osteoblastgenesis and osteoclastgenesis in culture and its therapeutic effects in rat osteopenia models Jpn J Pharmacol 79 1999 477 483
350. J.H. Wang, R.K. Sharma, and M.J. Mooibroek Calmodulin-stimulated cyclic nucleotide phospohdiesterases J. Beavo M.D. Houslay Cyclic Nucleotide Phosphodiesterases: Structure, Regulation and Drug Action 1990 John Wiley and Sons Ltd 19 59
351. P. Wang, P. Wu, R.W. Egan, and M.M. Billah Cloning, characterization, and tissue distribution of mouse phosphodiesterase 7A1 Biochem Biophys Res Commun 276 2000 1271 1277
352. P. Wang, P. Wu, R.W. Egan, and M.M. Billah Human phosphodiesterase 8A splice variants: cloning, gene organization, and tissue distribution Gene 280 2001 183 194
353. P. Wang, P. Wu, R.W. Egan, and M.M. Billah Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5). Differential tissue distribution and subcellular localization of PDE9A variants Gene 314 2003 15 27
354. J. Wechsler, Y.H. Choi, J. Krall, F. Ahmad, V.C. Manganiello, and M.A. Movsesian Isoforms of cyclic nucleotide phosphodiesterase PDE3A in cardiac myocytes J Biol Chem 277 2002 38072 38078
355. J.L. Weeks, R. Zoraghi, A. Beasley, K.R. Sekhar, S.H. Francis, and J.D. Corbin High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients Int J Impot Res 17 2005 5 9
356. R.E. Weishaar, D.C. Kobylarz-Singer, R.P. Steffen, and H.R. Kaplan Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility Circ Res 61 1987 539 547
357. J.N. Wells, C.E. Baird, Y.J. Wu, and J.G. Hardman Cyclic nucleotide phosphodiesterase activities of pig coronary arteries Biochim Biophys Acta 384 1975 430 442
358. M.E. Whalin, S.J. Strada, and W.J. Thompson Purification and partial characterization of membrane-associated type II (cGMP-activatable) cyclic nucleotide phosphodiesterase from rabbit brain Biochim Biophys Acta 972 1988 79 94
359. W. Wong, and J.D. Scott AKAP signalling complexes: focal points in space and time Nat Rev Mol Cell Biol 5 2004 959 970
360. S.N. Wu, H.F. Li, and H.T. Chiang Vinpocetine-induced stimulation of calcium-activated potassium currents in rat pituitary GH3 cells Biochem Pharmacol 61 2001 877 892
361. A.Y. Wu, X.B. Tang, S.E. Martinez, K. Ikeda, and J.A. Beavo Molecular determinants for cyclic nucleotide binding to the regulatory domains of phosphodiesterase 2A J Biol Chem 279 2004 37928 37938
362. R.X. Xu, A.M. Hassell, D. Vanderwall, M.H. Lambert, W.D. Holmes, and M.A. Luther Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity Science 288 2000 1822 1825
363. R.X. Xu, W.J. Rocque, M.H. Lambert, D.E. Vanderwall, M.A. Luther, and R.T. Nolte Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram J Mol Biol 337 2004 355 365
364. K. Yamaguchi, M. Oka, M. Nishino, N. Hanasato, S. Kira, and Y. Fukuchi E 4021, a cGMP phosphodiesterase inhibitor, is a selective pulmonary vasodilator in chronically hypoxic pulmonary hypertensive rats Nihon Kokyuki Gakkai Zasshi 36 1998 23 28
365. T. Yamamoto, S. Yamamoto, J.C. Osborne Jr., V.C. Manganiello, M. Vaughan, and H. Hidaka Complex effects of inhibitors on cyclic GMP-stimulated cyclic nucleotide phosphodiesterase J Biol Chem 258 1983 14173 14177
366. M. Yamazaki, N. Li, V.A. Bondarenko, R.K. Yamazaki, W. Baehr, and A. Yamazaki Binding of cGMP to GAF domains in amphibian rod photoreceptor cGMP phosphodiesterase (PDE). Identification of GAF domains in PDE alphabeta subunits and distinct domains in the PDE gamma subunit involved in stimulation of cGMP binding to GAF domains J Biol Chem 277 2002 40675 40686
367. C. Yan, A.Z. Zhao, J.K. Bentley, K. Loughney, K. Ferguson, and J.A. Beavo Molecular cloning and characterization of a calmodulin-dependent phosphodiesterase enriched in olfactory sensory neurons Proc Natl Acad Sci U S A 92 1995 9677 9681
368. C. Yan, A.Z. Zhao, J. Bentley, and K. Beavo The calmodulin-dependent phosphodiesterase gene PDE1C encodes several functionally different splice variants in a tissue-specific manner J Biol Chem 271 1996 25699 25706
369. C. Yan, A.Z. Zhao, W.K. Sonnenburg, and J.A. Beavo Stage and cell-specific expression of calmodulin-dependent phosphodiesterases in mouse testis Biol Reprod 64 2001 1746 1754
370. N. Yanaka, Y. Kurosawa, K. Minami, E. Kawai, and K. Omori CGMP-phosphodiesterase activity is up-regulated in response to pressure overload of rat ventricles Biosci Biochem 67 2003 973 979
371. Q. Yang, M. Paskind, G. Bolger, W.J. Thompson, D.R. Repaske, and L.S. Cutler A novel cyclic GMP stimulated phosphodiesterase from rat brain Biochem Biophys Res Commun 205 1994 1850 1858
372. G. Yang, K.W. McIntyre, R.M. Townsend, H.H. Shen, W.J. Pitts, and J.H. Dodd Phosphodiesterase 7A-deficient mice have functional T cells J Immunol 171 2003 6414 6420
373. J. Yu, S.L. Wolda, A.L. Frazier, V.A. Florio, T.J. Martins, and P.B. Snyder Identification and characterisation of a human calmodulin-stimulated phosphodiesterase PDE1B1 Cell Signal 9 1997 519 529
374. K. Yuasa, J. Kotera, K. Fujishige, H. Michibata, T. Sasaki, and K. Omori Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression J Biol Chem 275 2000 31469 31479
375. K. Yuasa, T. Ohgaru, M. Asahina, and K. Omori Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): comparison of rat and human PDE11A splicing variants Eur J Biochem 268 2001 4440 4448
376. H.T. Zhang, Y. Huang, S.L. Jin, S.A. Frith, N. Suvarna, and M. Conti Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme Neuropsychopharmacology 27 2002 587 595
377. R. Zhang, Y. Wang, L. Zhang, Z. Zhang, W. Tsang, and M. Lu Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats Stroke 33 2002 2675 2680
378. A.Z. Zhao, K.E. Bornfeldt, and J.A. Beavo Leptin inhibits insulin secretion by activation of phosphodiesterase 3B J Clin Invest 102 1998 869 873
379. A.Z. Zhao, J.N. Huan, S. Gupta, R. Pal, and A. Sahu A phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding Nat Neurosci 5 2002 727 728
380. R. Zoraghi, J.D. Corbin, and S.H. Francis Properties and functions of GAF domains in cyclic nucleotide phosphodiesterases and other proteins Mol Pharmacol 65 2004 267 278